Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
, optical physics, atomic and molecular physics, plasma physics, soft matter physics, and condensed matter theory and computational physics. There are 12 laboratories and 8 centers in our research system
-
an expected starting date in early 2026, in the Cuernavaca branch of the Institute in the state of Morelos, Mexico. UNAM is Mexico's leading university and is home to some of the most prominent research
-
achievements in one or more of the following research areas: High-energy physics, including: particle physics, cosmology, astroparticles, quantum field theory, and nuclear physics. Quantum physics and optics
-
theory, and machine learning to quantify and understand cancer biology. We are seeking a highly motivated Postdoctoral Researcher to develop new computational methods for the analysis and interpretation
-
for fundamental theory and experimental breakthroughs. Here, individuals can experience a conducive environment for their academic and collaborative development. CIS adopts a dual appointment system of full-time
-
/Utilization Technology · Rank: Assistant professor ○ Undergraduate Faculty 5. Physics · Condensed Matter Physics (including Solid-state Physics and Statistical Physics) Experiment or Theory, Nuclear Physics
-
academic theories. Academicians of the Chinese Academy of Sciences and Chinese Academy of Engineering can be directly appointed as tenured professors. (2) In principle, tenure-track associate professors
-
I. About the School The School of Sustainable Energy and Resources (hereinafter referred to as SSER) of Nanjing University (hereinafter referred to as NJU) is one of the key schools founded on NJU’s
-
About This Role: We are seeking a highly motivated and accomplished Senior Scientist with drug discovery experience in diseases with an inflammatory etiology to join our growing Immunology team
-
About This Role: The Biogen West Coast Hub (WCH) is focused on transforming the lives of patients with severe immune mediated diseases by developing novel targeted therapies with outsized clinical